Design of the EMPERIAL-reduced trial of empagliflozin in patients with chronic heart failure with reduced ejection fraction

Back

HFA Premium Access

Design of the EMPERIAL-reduced trial of empagliflozin in patients with chronic heart failure with reduced ejection fraction

Session: Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Professor W. Abraham (Columbus, US)

Event: Heart Failure 2018

Congress Presentation

About the speaker

Professor William Abraham

The Ohio State University, Columbus (United States of America)

61 presentations

2 followers

43 more presentations in this session

Relationship of circulating plasma levels of D-Dimer and outcome in patients with heart failure: findings from BIOSTAT-CHF

Speaker: Doctor P. Pellicori (Glasgow, GB)

Access

Abstract

Left ventricular ejection fraction, systolic blood pressure and smoking history are good predictors of respiratory muscle weakness in systolic heart failure

Speaker: Miss M. Diz (Sao Paulo, BR)

Access

Abstract

Correlation between Th1, Th2, Th17, and Treg cytokines serum levels with autonomic function in patients with chronic Chagas disease and systemic arterial hypertension

Speaker: Professor R. Bestetti (Ribeirao Preto, BR)

Access

Abstract

Slides

Impact of left ventricular assist device implantation on right and left ventricular volumes and functions

Speaker: Doctor S. Cazalbou (Toulouse, FR)

Access

Abstract

The effect of standard treatment of acute decompensation of heart failure at the concentration of omega-3 and omega-6 polyunsaturated fatty acids in whole blood

Speaker: Miss A. Zaplatina (Saint Petersburg, RU)

Access

Abstract

Access the full session

Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms

Speakers: Professor W. Abraham, Doctor P. Pellicori, Miss M. Diz, Professor R. Bestetti, Doctor S. Cazalbou...

Access

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

Design of the EMPERIAL-reduced trial of empagliflozin in patients with chronic heart failure with reduced ejection fraction

About the speaker

Professor William Abraham

43 more presentations in this session

Relationship of circulating plasma levels of D-Dimer and outcome in patients with heart failure: findings from BIOSTAT-CHF

Left ventricular ejection fraction, systolic blood pressure and smoking history are good predictors of respiratory muscle weakness in systolic heart failure

Correlation between Th1, Th2, Th17, and Treg cytokines serum levels with autonomic function in patients with chronic Chagas disease and systemic arterial hypertension

Impact of left ventricular assist device implantation on right and left ventricular volumes and functions

The effect of standard treatment of acute decompensation of heart failure at the concentration of omega-3 and omega-6 polyunsaturated fatty acids in whole blood

Access the full session

Poster Session 3 - Chronic Heart Failure – Pathophysiology and Mechanisms

About the event

Heart Failure 2018

ESC 365 is supported by